On Saturday, December 4, 2021, starting at 10:00 p.m. EST we will be launching the New FAST Graphs. This may cause temporary interruptions. We are sorry for any inconvenience this may cause.

MRK

Merck & Company (MRK) Blue-Chip Dividend Growth Stock On Sale

2021-05-28

Research Articles

Dividend Growth Stock On Sale Merck & Company (MRK) is what I consider to be a very high quality blue-chip dividend growth stock that promises both some good current income and growth of future income, as well as capital appreciation.  Most importantly of all, I believe it’s very attractively-valued today.  In this video I am […]

Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5

2017-10-19

Research Articles

Introduction Thus far, with the first 3 parts of this five-part series, we’ve examined 60% (18 of 30) of the 30 stocks in the Dow Jones Industrial Average.  What we found so far were that the majority of these constituents are currently overvalued or at least fully valued.  Finally, with this Part 4, we will […]

Dissecting the Dow: 21 of the 30 Dow Stocks are Undervalued, 6 are Fairly Valued, and Only 3 Appear Overvalued

2011-10-19

Research Articles

Introduction In this final segment, we will cover the 10 poorest performing DJIA stocks since 1995.  In part one which covered the best 10 performing DJIA stocks; we saw a group of companies that could best be described as consistent above-average earnings generators.  Consequently, it makes sense that they were the best performers since we […]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?

2011-01-12

Research Articles

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.